Company news
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A (SSE:605199) news
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A news releases on 6ix. Latest, Oct 18, 2025: Announcement on Proposed Signing of Technology Cooperation…
Press releases — page 2
Announcement on Proposed Signing of Technology Cooperation and Development Contract with a Related Party and Related Party Transaction
October 17, 2025
Announcement on Election of Employee Representative Directors for the 4th Board of Directors
October 15, 2025
Announcement on Election of New Board of Directors
September 29, 2025
Announcement on the Company and Its Wholly-owned Subsidiary Obtaining Drug Registration Certificate
September 15, 2025
Announcement on Obtaining Drug Registration Certificate for Cefdinir Capsules
September 5, 2025
Announcement on Resolutions of the 6th Meeting of the 3rd Board of Directors
August 29, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
August 20, 2025
Announcement on By-election of Director
August 5, 2025
Announcement on the Release of Pledged Shares by Shareholder
August 4, 2025
Supplementary Announcement on Providing Guarantee for Wholly-owned Subsidiary
July 30, 2025
Announcement on Retirement of Director and Senior Management Member
July 21, 2025
Announcement on Cefotaxime Sodium for Injection Passing the Generic Drug Consistency Evaluation
July 17, 2025
Semi-annual Earnings Preannouncement for 2025
July 14, 2025
Announcement on Obtaining Drug Registration Certificate for Cefprozil Oral Suspension
July 10, 2025
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2024 Annual Report
July 4, 2025